Decrease in visceral fat following diet-induced weight loss in upper body compared to lower body obese premenopausal women. 2006

Janneke G Langendonk, and Petra Kok, and Marijke Frölich, and Hanno Pijl, and A Edo Meinders
Department of General Internal Medicine, Leiden University Medical Centre, Postbox 9600, Albinusdreef 2, 2300RC, Leiden, The Netherlands.

BACKGROUND Obesity is associated with numerous metabolic disturbances, such as insulin resistance, diabetes mellitus type 2, dyslipidemia, and hypertension. An excess of fat within the abdomen, so-called visceral adiposity, confers a greater and independent health risk of metabolic and cardiovascular complications than does adipose tissue accumulation elsewhere. The present study aimed to investigate a possible differential effect of diet-induced weight loss in visceral fat mass and metabolic parameters in obese individuals with the upper body (UBO) and lower body (LBO) obese phenotype. METHODS The obese subjects were prescribed a liquid, very-low calorie diet to reduce 50% of their overweight (15% body weight loss). Specific body fat measurements (MRI, BIA), anthropometrics, and fasting metabolic parameters were obtained in control subjects and two groups of obese subjects (UBO and LBO) before and after weight loss. RESULTS Weight loss was accompanied by significant decreases in total, subcutaneous, and visceral fat in both UBO and LBO women. The largest reduction in visceral fat mass was found in the UBO women (absolute decrease 223+/-32 cm(2) vs 122+/-91 cm(2) in LBO women; P=0.01), while the amount of visceral fat was reduced to normal levels in LBO women (155+/-25 cm(2) after weight loss vs 143+/-17 cm(2) in controls; P=NS). Furthermore, weight loss significantly lowered fasting glucose, total cholesterol, and LDL cholesterol concentrations in UBO women. CONCLUSIONS The obese phenotype is preserved after body weight loss. UBO women have to lose a larger amount of overweight in order to bring the amount of fat in the visceral depot down to normal levels and to obtain normalization of their cardiovascular risk profile.

UI MeSH Term Description Entries

Related Publications

Janneke G Langendonk, and Petra Kok, and Marijke Frölich, and Hanno Pijl, and A Edo Meinders
January 1993, The American journal of clinical nutrition,
Janneke G Langendonk, and Petra Kok, and Marijke Frölich, and Hanno Pijl, and A Edo Meinders
January 1989, The American journal of clinical nutrition,
Janneke G Langendonk, and Petra Kok, and Marijke Frölich, and Hanno Pijl, and A Edo Meinders
May 1998, The Journal of clinical endocrinology and metabolism,
Janneke G Langendonk, and Petra Kok, and Marijke Frölich, and Hanno Pijl, and A Edo Meinders
July 1993, The American journal of clinical nutrition,
Janneke G Langendonk, and Petra Kok, and Marijke Frölich, and Hanno Pijl, and A Edo Meinders
July 2019, The Journal of nutritional biochemistry,
Janneke G Langendonk, and Petra Kok, and Marijke Frölich, and Hanno Pijl, and A Edo Meinders
November 2011, Medical science monitor : international medical journal of experimental and clinical research,
Janneke G Langendonk, and Petra Kok, and Marijke Frölich, and Hanno Pijl, and A Edo Meinders
May 2011, International journal of obesity (2005),
Janneke G Langendonk, and Petra Kok, and Marijke Frölich, and Hanno Pijl, and A Edo Meinders
April 1995, International journal of obesity and related metabolic disorders : journal of the International Association for the Study of Obesity,
Janneke G Langendonk, and Petra Kok, and Marijke Frölich, and Hanno Pijl, and A Edo Meinders
January 2022, Journal of nutritional science and vitaminology,
Janneke G Langendonk, and Petra Kok, and Marijke Frölich, and Hanno Pijl, and A Edo Meinders
August 1992, Metabolism: clinical and experimental,
Copied contents to your clipboard!